Dosing schedule and duration not defined: CDSCO panel tells Windlas Biotech on antihypertensive FDC Drug Dr. Divya Colin1 Oct 2022 5:00 PM ISTNew Delhi: Citing that dosing schedule and duration was not defined, the Subject Expert Committee (SEC) functional under Central Drug Standard Control...
Combining ARBs, CCBs and Diuretics in controlling Resistant Hypertension in CV patients: Review Dr. Prem Aggarwal12 Nov 2021 12:57 PM ISTA significant increase in resistant hypertension (RH) has been documented in the last decade, with epidemiological data suggesting that the rise has...
Chlorthalidone improves BP control in CKD patients with uncontrolled hypertension: NEJM Medha Baranwal12 Nov 2021 1:37 AM ISTUSA: A recent study has shown that chlorthalidone therapy improved blood-pressure control at 12 weeks in patients with advanced chronic kidney disease...
NPPA fixes retail price of 23 formulations; details Medical Dialogues Team27 Sept 2021 4:37 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India,...
Chlorthalidone more effective in reducing MACE than HCTZ in long run: Study Dr. Nandita Mohan18 Feb 2021 10:30 PM ISTResearchers from the NYU School of Medicine, New York City, New York, USA have recently observed that over the short-term there were no differences in...
Chlorthalidone more effective than HCTZ in reducing MACE in long term: Study Dr. Nandita Mohan24 Jan 2021 9:30 PM ISTAccording to recent research, investigators from the NYU School of Medicine, New York City, New York, USA found out that over the short-term there...
Managing Difficult to Treat Hypertension with Newer ARBs Prof. Soumitra Kumar18 July 2020 12:15 PM ISTA considerable number of patients with hypertension remain resistant to treatment despite the many therapeutic options available today for...
Chlorthalidone use linked to higher hypokalemia rates than hydrochlorothiazide: JAMA Dr. Kamal Kant Kohli18 Feb 2020 10:36 AM ISTDiuretics have demonstrated favorable blood pressure lowering efficacy, but the equivalent doses of their more common agents, chlorthalidone and...
